Theragenics Corp (NYSE:TGX)

Small biotech firm flying under the radar.

Growth looks promising

I'm well acquainted with this company. Their products are superior to anything in the marketplace. It is just a matter of increased marketing. If you know anyone with prostate cancer then please direct them to the Theragenics website. This is the cure --and the one Major Guilianni chose for his cancer.

may gain a star or two and scouter points. Will be watching

Its a low priced stock, and I believe more small investors can afford it regardless of its value.

This one has been building a cup and handle pattern over the past few years. Building out the handle now. With the population getting older there will be more need for their products.

I don't know why but I just hate this stock.

Theragenics is mostly a manufacturer and supplier of brachytherapy technology TheraSeed, used to cure prostate cancer in a minimally invasive way. Demographics indicate there are a lot of old people coming our way, and with them likely cancers.

The company is solid and should grow profits in the coming years. Stock is currently trading near 52 week low.

Theragenics is one of the select few healthcare companies that really does provide a nice value. TGX is trading below book value and at just 15-20 times forward earnings estimates. Revenue growth has been steadily showing 10-12M increases for 4 years now and they are set with more than 45 million in cash and only 7 million in debt. The long-term downtrend has been broken as of earlier this year so it should be able to mount a run at its yearly highs of 2007 in 2008/2009. There's no reason these fundamentals should go unnoticed.

Nero

Sagetrade

Recovery play.

Good earnings growth over the last few quarters and a solid balnce sheet. Over a buck / share cash on a $3.50 stock.

stat reject

I"ve gone from bear to bull on this one.Looking for a short term gain.

good looking fundamentals, increasing profits and trading at a book of 1.2. Fantastic opportunity to get in early?

very positive earnings and outlook ahead!

Theragenics has recently gotten it's act together and started to make some money. With the addition of some device lines adding to the seed business they are starting to act like a true business instead of a startup.

Speculative small cap cancer treatment company with a lot of potential.

Theragenics Corporation is a medical device company serving the cancer treatment and surgical markets with TheraSeed, its palladium-103 prostate cancer treatment device, and wound closure and other medical products manufactured and sold through its CP Medical Corporation (CP Medical) subsidiary. It also manufactures and distributes I-Seed, its iodine-125-based prostate cancer treatment device. Theragenics is a producer of palladium-103, the radioactive isotope that supplies the therapeutic radiation for its TheraSeed device. The Company operates in two segments: the brachytherapy seed segment and the CP Medical wound closure and medical products segment. The brachytherapy seed segment consists of the Company's TheraSeed and I-Seed products, as well as related products and services. CP Medical is a manufacturer and distributor of wound closure and other medical products sold in the professional surgical and veterinary fields. In August 2006, the Company acquired Galt Medical Corp.

A small cap cancer treatment company with no analyst coverage spells potential pocket rocket! Another speculative small cap company with a good foundation and in a sector with tremendous growth potential. At only $5 and change...what do you have to lose!